Our previous study showed that AC of CD4+ cells had a predictive value in longer PFS of NSCLC, while the percentages of CD3+, CD4+, CD8+, B, and NK cells were the same as that in NCs, with no difference between the two groups (36). This evidence concerns the gene CD8A and non-small cell lung carcinoma.